Literature DB >> 7008299

[Uncharacteristic dyspepsia in general practice. A controlled trial with an antacid (Alminox)].

N Nørrelund, A Helles, M Schmiegelow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7008299

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


× No keyword cloud information.
  6 in total

1.  Economic costs of functional dyspepsia.

Authors:  O Nyrén; G Lindberg; E Lindström; R Seensalu
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

2.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Helicobacter pylori eradication ameliorates symptoms and improves quality of life in patients on long-term acid suppression. A large prospective study in primary care.

Authors:  S Verma; M H Giaffer
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

4.  Long term acid suppressing treatment in general practice.

Authors:  S D Ryder; S O'Reilly; R J Miller; J Ross; M R Jacyna; A J Levi
Journal:  BMJ       Date:  1994-03-26

Review 5.  Functional dyspepsia. Current treatment recommendations.

Authors:  Gerald Holtmann; Nicholas J Talley
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

6.  Antacid (A02A) and antiulcer (A02B) drug prescription patterns: predicting factors, dosage and treatment duration.

Authors:  M M Morales Suárez-Varela; M A Pérez-Benajas; V J Girbes Pelechano; A Llopis-González
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.